RankAlpha logo
Back to Rankings

IRD

Opus GeneticsF
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
View Chart
Current thesis
Successful clinical/data milestones or a strategic partnership/licensing deal could materially re-rate the stock, validating platform potential and improving near-term financing prospects.
Posture
Defensive
Lead driver
Value
What changed
Value remains the lead driver in the composite, 7D delta -0.0.
What can break
Clinical trial failure or negative data readout
Momentum
80
Value
41
Sentiment
0
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $1.82 · Bull $2.91 · Bear $0.91Analysis 2025-09-29; returns require an exact persisted reference.
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-08-17 • Vendor: Data Vendor v1
Scores
As of 2026-09-10 • Model: HYBRID_IC_RP
AI Memo
As of 2025-09-29 • Model: RankAlpha Sentiment AI
Investment thesis
As of 2026-09-10

Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-09-10. Definitions

Supporting evidence
What
Grade F · Defensive
Confidence Medium · Net Neutral
Target $13.00
Why
Momentum80 · Δ7d +38.8
Value41 · Δ7d -0.0
Sentiment0 · Δ7d 0.0
So what
Weak posture (Net Neutral). Prioritize risk control and patience.

Confirming evidence

  • Value remains the lead driver in the composite, 7D delta -0.0.

Contradictions & invalidation

  • Clinical trial failure or negative data readout
  • Inability to raise non-dilutive capital or adverse financing terms
  • Clinical setbacks, inability to secure non-dilutive financing, or persistent low liquidity could drive further downside and shareholder dilution.

Catalyst clock

No dated catalyst is available.

Lead driver: Value · See fundamentals
Momentum
80
9% active weight
Current posture
7d trendImproving
Δ7d
+38.8
Δ21d
+57.9
Value
41
28% active weight
Current posture
7d trendFlat
Δ7d
-0.0
Δ21d
+0.1
Sentiment
0
62% active weight
Current posture
7d trendFlat
Δ7d
0.0
Δ21d
0.0
Why this grade

Composite grade F. Momentum 80.1 / Value 41.2 / Sentiment 0.0

Scenario snapshot

Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2025-09-29. Scenario method

B+
Bull case
20%
Probability
Target price
$2.91
Analysis reference price unavailable
Analysis 2025-09-29 · RankAlpha Sentiment AI
Most likely
B
Base case
60%
Probability
Target price
$1.82
Analysis reference price unavailable
Analysis 2025-09-29 · RankAlpha Sentiment AI
B-
Bear case
20%
Probability
Target price
$0.91
Analysis reference price unavailable
Analysis 2025-09-29 · RankAlpha Sentiment AI
Fundamentals (TTM)
As of 2026-08-17
Market Cap
$303.67M
Beta
0.58
Shares Out
83.2M
P/E (TTM) · Derived
-4.6
P/S (TTM)
10.04
P/FCF (TTM) · Derived
-7.58
Rev YoY
-73.8%
EPS YoY
+18.7%
Gross Margin
+99.5%
Op Margin
-513.5%
Net Debt
-$43.96M
Current Ratio
12.19
As of 2026-09-10 • Updated nightlySource: Internal modelMethods & Data